Results 71 to 80 of about 5,347 (209)
Background Apixaban is commonly used in anticoagulation therapy. Its safety profile is associated with polypharmacy and potential drug–drug interactions (DDIs). Current understanding often focuses on canonical metabolic pathways, while other biological factors of haemorrhagic risk remain not fully described.
Zhuang Chen +3 more
wiley +1 more source
Aim. To assess the effects of metabolic therapy, administered together with standard antianginal treatment, on large artery elasticity and endotheliumdependent vasodilation in patients with stable angina and subsequent heart failure. Material and methods.
O. V. Ilukhin +5 more
doaj
Purpose: Cardiologists are known to consider patients' race when treating heart failure, but their views on the benefits and harms of this practice are largely undocumented.
Shawneequa L. Callier +4 more
doaj +1 more source
HFrEF pharmacological treatment: hydralazine and isosorbide dinitrate
The use of hydralazine and isosorbide dinitrate in combination with renin–angiotensin blockade and evidence-based beta-blocker therapy is an accepted therapy for heart failure with reduced ejection fraction (HFrEF).
Clyde W. Yancy, Faraz S. Ahmad
core +1 more source
A group of nitrate derivatives of naturally occurring sauropunol A and B were designed and synthesized. Nitric oxide (NO) releasing capacity and vasodilatory capacity studies were performed to explore the structure-activity relationship of resulted ...
Lu Lu +9 more
doaj +1 more source
PURPOSE: In an effort to improve radiotherapy treatments, methods aimed at increasing the quantity of oxygen delivered to tumors were investigated. The aim of this study was to evaluate the effect of one nitric oxide (NO) donor (isosorbide dinitrate) on ...
Bernard Gallez +11 more
core +1 more source
Hydralazine-Isosorbide Dinitrate Use in Patients With End-Stage Kidney Disease on Dialysis. [PDF]
Mavrakanas TA, Soomro QH, Charytan DM.
europepmc +1 more source
Antianginal treatment and quality of life in patients with chronic coronary heart disease
Aim. To assess the effects of various antianginal nitrate therapy variants on quality of life (QoL) in patients with chronic coronary heart disease (CHD). Material and methods.
B. I. Geltser +4 more
doaj
Rats dosed orally with isosorbide dinitrate (1 mg kg−1) were exposed to smoke from standard and nicotine-reduced cigarettes for 8 min using a smoking machine.
Katsushi Furuno +2 more
core +1 more source
Retracted: The Clinical Efficacy of Cedilanid and Isosorbide Dinitrate plus Pericardial Dissection for Chronic Constrictive Pericarditis in the Elderly and Its Influence on Plasma Endothelin, Atrial Natriuretic Peptide, and Systemic Immune-Inflammation Index. [PDF]
And Alternative Medicine EC.
europepmc +1 more source

